Stocks · Health care · Biological Products, (No Diagnostic Substances)

aTYR PHARMA INC

ATYR Clue Score30

United States Fiscal year ends December CIK 0001339970 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

5 insiders · 4 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Paul Schimmel

Director

$49.63K (1)

—

+$49.63K

779,143

0.7943%

$386.69K

—

Sanjay Shukla

President and CEO

—

$3.66K (1)

−$3.66K

153,553

0.1565%

$76.21K

+12.5%

Jill Marie Broadfoot

Chief Financial Officer

—

$1.52K (1)

−$1.52K

37,296

0.0380%

$18.51K

+14.4%

Nancy Denyes

General Counsel

—

$1.09K (1)

−$1.09K

33,124

0.0338%

$16.44K

+11.3%

Jane A Gross

Director

—

—

—

9,750

0.0099%

$4.84K

+62.5%